Evidence map›Paper›PMID 31138820›Full record

ArticleScientific reports2019

Clinical courses and complications of young adults with Autosomal Recessive Polycystic Kidney Disease (ARPKD).

Kathrin Burgmaier, Samuel Kilian, Bert Bammens, Thomas Benzing, Heiko Billing, Anja Büscher, Matthias Galiano, Franziska Grundmann, Günter Klaus, Djalila Mekahli and 14 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Deciphering the Impact of RAC1-SPTAN1 in ARPKD Cystogenesis Using Multifaceted Models.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Polycystic Kidney Disease in Children: The Current Status and the Next Horizon.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2025
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 13 institutions in 6 countries.

Kathrin BurgmaierDepartment of Pediatrics, University Hospital of Cologne, Cologne, Germany.
Samuel KilianInstitute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany.
Bert BammensDepartment of Microbiology and Immunology, Laboratory of Nephrology, KU Leuven, Leuven, Belgium.
Thomas BenzingDepartment II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
Heiko BillingChildren's University Hospital Tuebingen, Department of General Pediatrics and Hematology/Oncology, Tuebingen, Germany.
Anja BüscherDepartment of Pediatrics II, University Hospital Essen, Essen, Germany.
Matthias GalianoDepartment of Pediatrics and Adolescent Medicine, Hospital of the Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Franziska GrundmannDepartment II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
Günter KlausKfH Center of Paediatric Nephrology, University Hospital of Marburg, Marburg, Germany.ORCID http://orcid.org/0000-0001-9453-4326
Djalila MekahliPKD Research Group, Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
Laurence Michel-CalemardService Biochimie Biologie Moléculaire Grand Est, Hospices Civils de Lyon, Bron Cedex, France.
Gordana Milosevski-LomicDepartment of Nephrology, University Children's Hospital, Belgrade, Serbia.
Bruno RanchinPediatric Nephrology Unit, Hôpital Femme Mere Enfant, Hospices Civils de Lyon, Lyon, France.
Katja SauersteinDepartment of Pediatrics and Adolescent Medicine, Hospital of the Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Susanne SchaeferDivision of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany.
Rukshana ShroffGreat Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
Rosalie SterenborgGreat Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
Sarah VerbeeckDepartment of Pediatric Nephrology, University Hospitals Leuven, Leuven, Belgium.
Lutz T WeberDepartment of Pediatrics, University Hospital of Cologne, Cologne, Germany.
Dorota WicherDepartment of Medical Genetics, The Children's Memorial Health Institute, Warsaw, Poland.ORCID http://orcid.org/0000-0002-8360-0006
Elke WühlDivision of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany.
Jörg DötschDepartment of Pediatrics, University Hospital of Cologne, Cologne, Germany.
Franz SchaeferDivision of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany.
Max C LiebauDepartment of Pediatrics, University Hospital of Cologne, Cologne, Germany. max.liebau@uk-koeln.de.ORCID http://orcid.org/0000-0003-0494-9080
Heidelberg University · DEKU Leuven · BEUniversity Hospital Cologne · DEUniversity of Cologne · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEGreat Ormond Street Hospital for Children NHS Foundation Trust · GBChildren's Memorial Health Institute · PLEssen University Hospital · DEHôpital Femme Mère Enfant · FRHospices Civils de Lyon · FRPhilipps University of Marburg · DEUniversity Children's Hospital, Belgrade · RSUniversity Children's Hospital Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autosomal recessive polycystic kidney disease (ARPKD) is a severe pediatric hepatorenal disorder with pronounced phenotypic variability. A substantial number of patients with early diagnosis reaches adulthood and some patients are not diagnosed until adulthood. Yet, clinical knowledge about adult ARPKD patients is scarce. Here, we describe forty-nine patients with longitudinal follow-up into young adulthood that were identified in the international ARPKD cohort study ARegPKD. Forty-five patients were evaluated in a cross-sectional analysis at a mean age of 21.4 (±3.3) years describing hepatorenal findings. Renal function of native kidneys was within CKD stages 1 to 3 in more than 50% of the patients. Symptoms of hepatic involvement were frequently detected. Fourteen (31%) patients had undergone kidney transplantation and six patients (13%) had undergone liver transplantation or combined liver and kidney transplantation prior to the visit revealing a wide variability of clinical courses. Hepatorenal involvement and preceding complications in other organs were also evaluated in a time-to-event analysis. In summary, we characterize the broad clinical spectrum of young adult ARPKD patients. Importantly, many patients have a stable renal and hepatic situation in young adulthood. ARPKD should also be considered as a differential diagnosis in young adults with fibrocystic hepatorenal disease.

Indexed as

AdolescentAdultCross-Sectional StudiesFemaleHumansKidneyKidney TransplantationLiverLiver CirrhosisLiver TransplantationLongitudinal StudiesMalePolycystic Kidney, Autosomal RecessiveRenal Insufficiency, ChronicYoung Adult

Identifiers

PMID31138820
PMCPMC6538621
OpenAlexW2947270494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.